This comprehensive analysis underscores ZDHHC9’s crucial function in BC, demonstrating its value as a prognostic biomarker and treatment target, thus establishing a conceptual foundation for the molecular diagnosis and clinical management of BC. This evidence concerns the gene ZDHHC9 and breast cancer.